company background image
GSS logo

Genetic Signatures ASX:GSS Stock Report

Last Price

AU$0.72

Market Cap

AU$156.1m

7D

7.4%

1Y

42.2%

Updated

23 Jun, 2024

Data

Company Financials +

Genetic Signatures Limited

ASX:GSS Stock Report

Market Cap: AU$156.1m

GSS Stock Overview

Operates as a molecular diagnostic (MDx) company in Australia, the Asia Pacific, the Americas, Europe, the Middle East, Israel, and Africa.

GSS fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Genetic Signatures Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Genetic Signatures
Historical stock prices
Current Share PriceAU$0.72
52 Week HighAU$0.85
52 Week LowAU$0.38
Beta0.14
11 Month Change-0.68%
3 Month Change10.69%
1 Year Change42.16%
33 Year Change-38.30%
5 Year Change-46.30%
Change since IPO49.48%

Recent News & Updates

Getting In Cheap On Genetic Signatures Limited (ASX:GSS) Might Be Difficult

Jun 14
Getting In Cheap On Genetic Signatures Limited (ASX:GSS) Might Be Difficult

After Leaping 42% Genetic Signatures Limited (ASX:GSS) Shares Are Not Flying Under The Radar

Mar 08
After Leaping 42% Genetic Signatures Limited (ASX:GSS) Shares Are Not Flying Under The Radar

Recent updates

Getting In Cheap On Genetic Signatures Limited (ASX:GSS) Might Be Difficult

Jun 14
Getting In Cheap On Genetic Signatures Limited (ASX:GSS) Might Be Difficult

After Leaping 42% Genetic Signatures Limited (ASX:GSS) Shares Are Not Flying Under The Radar

Mar 08
After Leaping 42% Genetic Signatures Limited (ASX:GSS) Shares Are Not Flying Under The Radar

A Look At The Fair Value Of Genetic Signatures Limited (ASX:GSS)

Nov 14
A Look At The Fair Value Of Genetic Signatures Limited (ASX:GSS)

Genetic Signatures Limited (ASX:GSS) Investors Are Less Pessimistic Than Expected

Oct 10
Genetic Signatures Limited (ASX:GSS) Investors Are Less Pessimistic Than Expected

One Genetic Signatures Limited (ASX:GSS) Analyst Just Made A Major Cut To Next Year's Estimates

Jun 29
One Genetic Signatures Limited (ASX:GSS) Analyst Just Made A Major Cut To Next Year's Estimates

Genetic Signatures (ASX:GSS) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Feb 28
Genetic Signatures (ASX:GSS) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

AU$3.20: That's What Analysts Think Genetic Signatures Limited (ASX:GSS) Is Worth After Its Latest Results

Feb 25
AU$3.20: That's What Analysts Think Genetic Signatures Limited (ASX:GSS) Is Worth After Its Latest Results

What Kind Of Shareholders Hold The Majority In Genetic Signatures Limited's (ASX:GSS) Shares?

Feb 07
What Kind Of Shareholders Hold The Majority In Genetic Signatures Limited's (ASX:GSS) Shares?

What Does Genetic Signatures' (ASX:GSS) CEO Pay Reveal?

Jan 17
What Does Genetic Signatures' (ASX:GSS) CEO Pay Reveal?

Genetic Signatures' (ASX:GSS) Wonderful 522% Share Price Increase Shows How Capitalism Can Build Wealth

Dec 27
Genetic Signatures' (ASX:GSS) Wonderful 522% Share Price Increase Shows How Capitalism Can Build Wealth

Genetic Signatures (ASX:GSS) Is In A Strong Position To Grow Its Business

Dec 06
Genetic Signatures (ASX:GSS) Is In A Strong Position To Grow Its Business

Shareholder Returns

GSSAU Life SciencesAU Market
7D7.4%5.0%0.8%
1Y42.2%-10.6%10.3%

Return vs Industry: GSS exceeded the Australian Life Sciences industry which returned -10.6% over the past year.

Return vs Market: GSS exceeded the Australian Market which returned 10.3% over the past year.

Price Volatility

Is GSS's price volatile compared to industry and market?
GSS volatility
GSS Average Weekly Movement4.9%
Life Sciences Industry Average Movement9.2%
Market Average Movement8.3%
10% most volatile stocks in AU Market16.1%
10% least volatile stocks in AU Market3.2%

Stable Share Price: GSS has not had significant price volatility in the past 3 months.

Volatility Over Time: GSS's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2001n/aNeil Gunnwww.geneticsignatures.com

Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in Australia, the Asia Pacific, the Americas, Europe, the Middle East, Israel, and Africa. It designs and manufactures a suite of real-time polymerase chain reaction-based products for detection of infectious diseases under the EasyScreen brand name. The company also provides MDx 3Base platform technology that enables hospital and pathology laboratories to screen for a range of infectious pathogens.

Genetic Signatures Limited Fundamentals Summary

How do Genetic Signatures's earnings and revenue compare to its market cap?
GSS fundamental statistics
Market capAU$156.08m
Earnings (TTM)-AU$18.04m
Revenue (TTM)AU$15.99m

9.8x

P/S Ratio

-8.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
GSS income statement (TTM)
RevenueAU$15.99m
Cost of RevenueAU$9.79m
Gross ProfitAU$6.20m
Other ExpensesAU$24.24m
Earnings-AU$18.04m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.084
Gross Margin38.79%
Net Profit Margin-112.83%
Debt/Equity Ratio0%

How did GSS perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.